SYK logo

STRYKER CORP

SYKNYSE
πŸ† #139 by market capEarnings Oct 29 Β· PostUS Equity
$278.22β–² $2.95 (+1.06%)
Live
πŸ””
Track SYK
Get earnings, price moves & breaking news on Telegram
Track
24hβ–² 1.1%
7dβ–² 1.1%
14dβ–Ό 1.2%
30dβ–Ό 15.9%
ytdβ–Ό 20.8%
1yβ–Ό 24.7%
🏦Market Cap
$106.66B
Mid Cap
πŸ“ˆRevenue Growth (YoY)
+8.5%
Slowing
πŸ“ŠGross Margin
65.3%
High
πŸ’΅FCF Margin
18.2%
Healthy
βš–οΈP/S Ratio
4.1x
Fair
Otter Score
72
Fair

Trading Snapshot

Day Range
$275.11 – $279.62
52-Week Range
$267.00 – $392.55
Volume
$7.77B
Avg Volume
$10.30B
Shares Outstanding
383.4M
Next Earnings
Nov 6, 2026

Fundamentals Snapshot

Annual Revenue
$25.12B
Last Q Revenue
$6.59B
P/E Ratio
28.3
P/S Ratio
4.1x
EPS (TTM)
$9.65
Dividend Yield
1.25%
Dilution (1yr)
+0.1%

Why Investors Own SYK

  • βœ“High-growth profile β€” revenue up +43.0% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 38% gross margin and 8% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

SYK logo

STRYKER CORP

SYK
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$25.1Bβ–² +11.2% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
64.0%β–² +3.4% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
$4.9Bβ–Ό βˆ’3.4% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$4.3Bβ–² +22.8% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
386.5Mβ–² +0.1% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
βˆ’$12.3Bβ–Ό βˆ’$1.9B YoY
StockOtter Β· stockotter.space

About STRYKER CORP

Stryker Corporation functions as a prominent medical technology enterprise, with its operations structured across two main divisions. The Orthopaedics and Spine segment specializes in providing implants for joint replacement procedures (including hips and knees), as well as solutions for trauma and extremities surgeries. This division also furnishes a comprehensive suite of spinal implant products, such as cervical, thoracolumbar, and interbody systems, utilized in addressing spinal injuries, deformities, and degenerative conditions. The MedSurg and Neurotechnology division offers an extensive array of products, encompassing advanced surgical equipment, surgical navigation systems, endoscopic and communication tools, patient handling devices, emergency medical apparatus, and critical care disposable items. This segment also deals in reprocessed and remanufactured medical devices, catering to various medical specialties. Furthermore, its neurotechnology offerings include devices for minimally invasive endovascular techniques, instruments for brain and open skull-based surgical interventions, and orthobiologic and biosurgery products like synthetic bone grafts and vertebral augmentation solutions. It also provides specialized minimally invasive products for treating acute ischemic and hemorrhagic strokes, alongside craniomaxillofacial implants, which include cranial, maxillofacial, and chest wall devices, in addition to dural substitutes and sealants. Stryker distributes its diverse portfolio to medical professionals, hospitals, and other healthcare institutions in approximately 75 countries, leveraging its network of company-owned subsidiaries, regional branches, and independent dealers and distributors. Established in 1941, Stryker Corporation is headquartered in Kalamazoo, Michigan.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Fair
72/100

Analyst Ratings

β“˜
Consensus
Buy
34 analysts
Strong Buy12
Buy15
Hold7
Sell0
Strong Sell0
Ratings as of Sep 2026

Latest News & Updates

Defense WorldΒ·3d ago

27,714 Stryker Corporation $SYK Shares Sold by Engineers Gate Manager LP

Engineers Gate Manager LP decreased its stake in Stryker Corporation (NYSE: SYK) by 96.1% during the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC)

Defense WorldΒ·4d ago

Envestnet Asset Management Inc. Purchases 70,634 Shares of Stryker Corporation $SYK

Envestnet Asset Management Inc. lifted its position in shares of Stryker Corporation (NYSE: SYK) by 12.2% in the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exch

PRNewsWireΒ·4d ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Stryker Corp. - SYK

NEW YORK, Sept. 24, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Stryker Corp. ("Stryker" or the "Company") (NYSE: SYK).

Zacks Investment ResearchΒ·6d ago

Intuitive Surgical vs. Stryker: Which MedTech Stock Is the Better Buy Now?

ISRG's rapid procedure growth, expanding robotics ecosystem and recurring revenues highlight its growth path amid MedTech shifts.

Zacks Investment ResearchΒ·6d ago

Can Stryker Vehicle Demand Support General Dynamics' Growth?

GD's Stryker contract modification lifts cumulative value to $278.9M, supporting Land Systems demand through December 2028.

Zacks Investment ResearchΒ·6d ago

Here's Why You Should Hold Stryker Stock in Your Portfolio for Now

SYK's resilient demand, Mako robotics growth and margin gains support its outlook despite cyber and supply disruptions.